Chhavi Agarwal
Pediatric Endocrinology · Scarsdale, NYNPI 1053407700
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 25.2% of the total. 2025 is the largest year on record at $780, 7.1 times the $110 reported in 2019.
Across 199 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$911
- Azurity Pharmaceuticals, Inc.$412
- Arbor Pharmaceuticals, Inc.$348
- Amneal Pharmaceuticals LLC$309
- Ascendis Pharma Endocrinology Inc$304
- Pfizer$255
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,56198%
- Education$572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $911 |
| Azurity Pharmaceuticals, Inc. | 22 | $412 |
| Arbor Pharmaceuticals, Inc. | 23 | $348 |
| Amneal Pharmaceuticals LLC | 17 | $309 |
| Ascendis Pharma Endocrinology Inc | 15 | $304 |
| Pfizer | 11 | $255 |
| Tolmar, Inc. | 11 | $243 |
| AstraZeneca | 9 | $174 |
| Novo Nordisk | 6 | $130 |
| Endo USA, Inc. | 5 | $98 |
| Endo Pharmaceuticals Inc. | 5 | $89 |
| Sandoz | 4 | $66 |
| Neurocrine Biosciences, Inc. | 3 | $60 |
| Eton Pharmaceuticals, Inc. | 1 | $36 |
| Tolmar Pharmaceuticals, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Biomarin Pharmaceutical Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Medtronic | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
How this compares
$3,618 in reported general payments places this provider in the 70th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Scarsdale
- Paul SaengerMineola$180K
- Alicia RomanoSleepy Hollow$157K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Moris AnguloMineola$73K
- Jill BrodskyPoughkeepsie$45K
- Jorge Mejia-CorlettoNorth Babylon$44K
- Angela VerardoBronx$38K
- Christopher RomeroNew York$35K
- Robert LevineMineola$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.